Analysis of costs and consequences related to the persistence of Mirabegron and antimuscarinic treatments and their impact on quality of life in patients with overactive bladder in Spain: Results of a probabilistic model.

To evaluate whether the lower dropout rate of the treatment of overactive bladde r(OAB) with mirabegron could generate cost savings to the National Health System (NHS) and lead to quality-adjusted life years (QALYs) gains, compared to the most commonly prescribed antimuscarinics (AM) in Spain (tolte...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Archivos españoles de urología 2020-07, Vol.73 (6), p.509-522
Hauptverfasser:	Arlandis Guzmán, Salvador, Jiménez Cidre, Miguel Ángel, Rubio-Rodríguez, Darío, Rubio-Terrés, Carlos, Landeira, Margarita, Blanco, Nuria
Format:	Artikel
Sprache:	spa
Schlagworte:	Acetanilides Humans Models, Statistical Muscarinic Antagonists - therapeutic use Quality of Life Spain Thiazoles Urinary Bladder, Overactive - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!